USPTO: New COVID-19 Provisional Application Pilot Program
USPTO Pilot Program enables deferred-fee payment related to filing of provisional patent applications that combat COVID-19
The United States Patent and Trademark Office (USPTO) launched a pilot program that allows deferring the payment of filing official fees for provisional patent applications that combat COVID-19, until the filing of a corresponding non-provisional application.
The applicants must agree that the technical subject matter disclosed in their provisional applications will be available to the public on USPTO’s website.
In this way, two objectives are achieved: by disseminating the technology, applicants contribute to the fight against COVID-19 while at the same time protecting their patent rights.
To qualify for the program, the subject matter disclosed in the provisional must concern a product or process related to COVID-19, and such product or process requires Food and Drug Administration (FDA) approval for COVID-19 use.
The program accepts applications as from September 17, 2020, for a duration of 12 months.
For more information, please click here.
BERKEN IP
Latest Posts
by BERKEN IPIAM Patent 1000: The World’s Leading Patent Professionals 2021
We are delighted to share that BERKEN IP has once again ranked in the “IAM Patent 1000: The World’s Leading Patent Professionals” guide. Three of our...
by Diego Federico MartinPatenting antibodies in Europe and Argentina
On March 1, 2021, the new Guidelines for Examination of the European Patent Office (EPO) came into force. These Guidelines set the rules by which Examiners...